ArticleExperimental & molecular medicine2024

Targeting pyruvate dehydrogenase kinase 1 overcomes EGFR C797S mutation-driven osimertinib resistance in non-small cell lung cancer.

Wonyoung Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.